KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Prepaid Assets (2017 - 2026)

Moderna (MRNA) has disclosed Prepaid Assets for 10 consecutive years, with $51.0 million as the latest value for Q1 2026.

  • For Q1 2026, Prepaid Assets fell 26.09% year-over-year to $51.0 million; the TTM value through Mar 2026 reached $51.0 million, down 26.09%, while the annual FY2025 figure was $45.0 million, 22.41% down from the prior year.
  • Prepaid Assets hit $51.0 million in Q1 2026 for Moderna, up from $45.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.4 billion in Q1 2023 and bottomed at $36.0 million in Q1 2022.
  • Average Prepaid Assets over 5 years is $439.3 million, with a median of $69.0 million recorded in 2025.
  • Year-over-year, Prepaid Assets surged 4496.15% in 2022 and then plummeted 94.97% in 2023.
  • Moderna's Prepaid Assets stood at $1.2 billion in 2022, then plummeted by 92.64% to $88.0 million in 2023, then crashed by 34.09% to $58.0 million in 2024, then dropped by 22.41% to $45.0 million in 2025, then increased by 13.33% to $51.0 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $51.0 million, $45.0 million, and $56.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.